| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Adenosine in cancer immunotherapy: Taking off on a new plane
|
Zhang, Chenyue
|
|
|
1878 |
6 |
p.
|
artikel
|
| 2 |
Antibody-drug conjugates in HER-2 negative breast cancers with poor prognosis
|
Püsküllüoğlu, Mirosława
|
|
|
1878 |
6 |
p.
|
artikel
|
| 3 |
Apoptosis, necroptosis, and pyroptosis as alternative cell death pathways induced by chemotherapeutic agents?
|
Gielecińska, A.
|
|
|
1878 |
6 |
p.
|
artikel
|
| 4 |
Artificial intelligence and allied subsets in early detection and preclusion of gynecological cancers
|
Garg, Pankaj
|
|
|
1878 |
6 |
p.
|
artikel
|
| 5 |
Biological function, regulatory mechanism, and clinical application of mannose in cancer
|
Jin, Haoyi
|
|
|
1878 |
6 |
p.
|
artikel
|
| 6 |
Caveolin-1 and lipids: Association and their dualism in oncogenic regulation
|
Bhowmick, Sramana
|
|
|
1878 |
6 |
p.
|
artikel
|
| 7 |
CD95 (Fas) and CD95L (FasL)-mediated non-canonical signaling pathways
|
Haymour, Layla
|
|
|
1878 |
6 |
p.
|
artikel
|
| 8 |
Changing landscape of anti-angiogenic therapy: Novel approaches and clinical perspectives
|
Gacche, Rajesh N.
|
|
|
1878 |
6 |
p.
|
artikel
|
| 9 |
Cuproptosis and cuproptosis-related genes: Emerging potential therapeutic targets in breast cancer
|
Liu, Xiangdong
|
|
|
1878 |
6 |
p.
|
artikel
|
| 10 |
Current and future directions of USP7 interactome in cancer study
|
Park, Hong-Beom
|
|
|
1878 |
6 |
p.
|
artikel
|
| 11 |
Current understanding of brachyury in chordoma
|
Ma, Tianshun
|
|
|
1878 |
6 |
p.
|
artikel
|
| 12 |
Dietary fat and lipid metabolism in the tumor microenvironment
|
Goswami, Swagata
|
|
|
1878 |
6 |
p.
|
artikel
|
| 13 |
Dissecting multifunctional roles of forkhead box transcription factor D1 in cancers
|
Cheng, Lin
|
|
|
1878 |
6 |
p.
|
artikel
|
| 14 |
Editorial Board
|
|
|
|
1878 |
6 |
p.
|
artikel
|
| 15 |
Efficacy and safety of trastuzumab with or without a tyrosine kinase inhibitor for HER2-positive breast cancer: A systematic review and meta-analysis
|
Li, Lixi
|
|
|
1878 |
6 |
p.
|
artikel
|
| 16 |
Emerging trends in post-translational modification: Shedding light on Glioblastoma multiforme
|
Kumari, Smita
|
|
|
1878 |
6 |
p.
|
artikel
|
| 17 |
Extracellular vimentin as a versatile immune suppressive protein in cancer
|
van Loon, Karlijn
|
|
|
1878 |
6 |
p.
|
artikel
|
| 18 |
Ferroptosis regulation by methylation in cancer
|
Hao, Mengqiu
|
|
|
1878 |
6 |
p.
|
artikel
|
| 19 |
Finding the junction between claudins and endometrial carcinoma
|
Capoferri, Davide
|
|
|
1878 |
6 |
p.
|
artikel
|
| 20 |
From resistance to resilience: Uncovering chemotherapeutic resistance mechanisms; insights from established models
|
Abdelmaksoud, Nourhan M.
|
|
|
1878 |
6 |
p.
|
artikel
|
| 21 |
Glioma and post-translational modifications: A complex relationship
|
Pienkowski, Tomasz
|
|
|
1878 |
6 |
p.
|
artikel
|
| 22 |
Harnessing tumor immunogenomics: Tumor neoantigens in ovarian cancer and beyond
|
Wu, Mengrui
|
|
|
1878 |
6 |
p.
|
artikel
|
| 23 |
Improving the efficacy of anti-EGFR drugs in GBM: Where we are going?
|
Ge, Manxi
|
|
|
1878 |
6 |
p.
|
artikel
|
| 24 |
Insights on the functional dualism of nitric oxide in the hallmarks of cancer
|
Panneerselvan, Prabha
|
|
|
1878 |
6 |
p.
|
artikel
|
| 25 |
Long non-coding RNAs in non-small cell lung cancer: implications for preventing therapeutic resistance
|
Liu, Wenjuan
|
|
|
1878 |
6 |
p.
|
artikel
|
| 26 |
Lyotropic liquid crystalline 2D and 3D mesophases: Advanced materials for multifunctional anticancer nanosystems
|
Araújo-Silva, Henrique
|
|
|
1878 |
6 |
p.
|
artikel
|
| 27 |
Master kinase PDK1 in tumorigenesis
|
Zheng, Nana
|
|
|
1878 |
6 |
p.
|
artikel
|
| 28 |
Metabolic reprogramming in nasopharyngeal carcinoma: Mechanisms and therapeutic opportunities
|
Liu, Qian
|
|
|
1878 |
6 |
p.
|
artikel
|
| 29 |
Microbial influence on triggering and treatment of host cancer: An intestinal barrier perspective
|
Zhang, Henan
|
|
|
1878 |
6 |
p.
|
artikel
|
| 30 |
Modulating the gut microbiota by probiotics, prebiotics, postbiotics, and fecal microbiota transplantation: An emerging trend in cancer patient care
|
Ciernikova, Sona
|
|
|
1878 |
6 |
p.
|
artikel
|
| 31 |
Multiple functions and dual characteristics of RAB11A in cancers
|
Guo, Rui-Jian
|
|
|
1878 |
6 |
p.
|
artikel
|
| 32 |
Multiple impacts of Naa10p on cancer progression: Molecular functions and clinical prospects
|
Ho, Kuo-Hao
|
|
|
1878 |
6 |
p.
|
artikel
|
| 33 |
Natural tyrosinase enzyme inhibitors: A path from melanin to melanoma and its reported pharmacological activities
|
Logesh, Rajan
|
|
|
1878 |
6 |
p.
|
artikel
|
| 34 |
New insights into RAS in head and neck cancer
|
Jagadeeshan, Sankar
|
|
|
1878 |
6 |
p.
|
artikel
|
| 35 |
Protein induced by vitamin K absence or antagonist II: Experience to date and future directions
|
Dong, Libin
|
|
|
1878 |
6 |
p.
|
artikel
|
| 36 |
Reflecting on the cardiac toxicity in non-small cell lung cancer in the era of immune checkpoint inhibitors therapy combined with thoracic radiotherapy
|
Luo, Yuxi
|
|
|
1878 |
6 |
p.
|
artikel
|
| 37 |
Role of stress granules in tumorigenesis and cancer therapy
|
Li, Tiansheng
|
|
|
1878 |
6 |
p.
|
artikel
|
| 38 |
Role of the intratumoral microbiome in tumor progression and therapeutics implications
|
Meng, Yu-Fan
|
|
|
1878 |
6 |
p.
|
artikel
|
| 39 |
RORγT agonists as immune modulators in anticancer therapy.
|
Pastwińska, Joanna
|
|
|
1878 |
6 |
p.
|
artikel
|
| 40 |
Small-molecule inhibitors targeting FOXM1: Current challenges and future perspectives in cancer treatments
|
Raghuwanshi, Sanjeev
|
|
|
1878 |
6 |
p.
|
artikel
|
| 41 |
Snail transcription factors as key regulators of chemoresistance, stemness and metastasis of ovarian cancer cells
|
Kielbik, Michal
|
|
|
1878 |
6 |
p.
|
artikel
|
| 42 |
S-Nitrosylation at the intersection of metabolism and autophagy: Implications for cancer
|
Guil-Luna, Silvia
|
|
|
1878 |
6 |
p.
|
artikel
|
| 43 |
Targeting STING in cancer: Challenges and emerging opportunities
|
Zhao, Kexin
|
|
|
1878 |
6 |
p.
|
artikel
|
| 44 |
The association between the neuroendocrine system and the tumor immune microenvironment: Emerging directions for cancer immunotherapy
|
Li, Jie
|
|
|
1878 |
6 |
p.
|
artikel
|
| 45 |
The dual role of citrate in cancer
|
Icard, Philippe
|
|
|
1878 |
6 |
p.
|
artikel
|
| 46 |
The interplay of obesity, microbiome dynamics, and innovative anti-obesity strategies in the context of endometrial cancer progression and therapeutic approaches
|
Burkett, Wesley C.
|
|
|
1878 |
6 |
p.
|
artikel
|
| 47 |
Therapy-induced senescence as a component of tumor biology: Evidence from clinical cancer
|
Saleh, Tareq
|
|
|
1878 |
6 |
p.
|
artikel
|
| 48 |
The role of dysregulated mRNA translation machinery in cancer pathogenesis and therapeutic value of ribosome-inactivating proteins
|
Jia, Wentao
|
|
|
1878 |
6 |
p.
|
artikel
|
| 49 |
The signaling pathways and targets of natural products from traditional Chinese medicine treating gastric cancer provide new candidate therapeutic strategies
|
Liao, Yile
|
|
|
1878 |
6 |
p.
|
artikel
|
| 50 |
The Warburg effect on radioresistance: Survival beyond growth
|
Kang, Hyunkoo
|
|
|
1878 |
6 |
p.
|
artikel
|
| 51 |
TRDMT1-mediated RNA C-5 methylation as a novel target in anticancer therapy
|
Lewinska, Anna
|
|
|
1878 |
6 |
p.
|
artikel
|
| 52 |
Tumor microenvironment diversity and plasticity in cancer multidrug resistance
|
Li, Zhi
|
|
|
1878 |
6 |
p.
|
artikel
|
| 53 |
Tunneling nanotubes: The intercellular conduits contributing to cancer pathogenesis and its therapy
|
Melwani, Pooja Kamal
|
|
|
1878 |
6 |
p.
|
artikel
|
| 54 |
Untangling the web of intratumor microbiota in lung cancer
|
Liu, Weici
|
|
|
1878 |
6 |
p.
|
artikel
|
| 55 |
20 years since the approval of first EGFR-TKI, gefitinib: Insight and foresight
|
Singh, Satyam
|
|
|
1878 |
6 |
p.
|
artikel
|
Tijdschrift beschrijving